Targeting Epigenetics in Ischemic Stroke: From Mechanisms to Therapeutics

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Ischemic stroke is a leading cause of global mortality and disability.
• Current treatments for ischemic stroke are limited due to complex pathophysiology.
• Epigenetics offers novel insights into gene regulation without altering DNA sequence.

Purpose of the Study:

• To systematically review the role of epigenetic mechanisms in ischemic stroke.
• To explore therapeutic targets within the epigenetic network for stroke treatment.
• To provide a basis for developing new diagnostic and treatment strategies.

Main Methods:

• Review of literature on DNA methylation, histone modification, and non-coding RNAs in ischemic stroke.
• Analysis of the involvement of epigenetic enzymes (DNMT, TET, HMT, HDM, HAT, HDAC) and non-coding RNAs.
• Discussion of current research on therapeutic drugs targeting epigenetic modifications.

Main Results:

• Epigenetic modifications influence key stroke processes like neuroinflammation, oxidative stress, and apoptosis.
• Targeted interventions on epigenetic enzymes and non-coding RNAs show potential for improving stroke outcomes.
• Epigenetic regulators are identified as significant therapeutic targets for ischemic stroke.

Conclusions:

• Epigenetic mechanisms are crucial in the development of ischemic stroke.
• Targeting epigenetic modifications presents a promising avenue for novel stroke therapies.
• Further research into epigenetic drugs could lead to improved clinical strategies for ischemic stroke.